The Goldman Sachs Group, Inc. 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 4:05 pm Purchase |
2024-12-31 | 13G | GeneDx Holdings Corp. WGS |
GOLDMAN SACHS GROUP INC GS |
1,421,903 5.200% |
84,798 (+6.34%) |
Filing |
| 2024-11-08 11:06 am Sale |
2024-09-30 | 13G | GeneDx Holdings Corp. WGS |
GOLDMAN SACHS GROUP INC GS |
1,337,105 5.000% |
-486,632 (-26.68%) |
Filing |
| 2024-02-09 7:10 pm Purchase |
2023-12-29 | 13G | GeneDx Holdings Corp. WGS |
GOLDMAN SACHS GROUP INC GS |
1,823,737 7.000% |
1,823,737 (New Position) |
Filing |